The Research and Development team at Constellation Pharmaceuticals focuses on discovering and developing innovative small molecule treatments that target epigenetic mechanisms in tumor and immune cells. Comprising experts across scientific and clinical disciplines, the team collaborates to advance drug candidates from early-stage discovery through clinical development, leveraging cutting-edge computational biology, translational research, and biomarker strategies to benefit patients with cancer.
Artyom Alekseyenko
Senior Scientist I
Ashlesh Sheth
Sr Director, Drug Product Deve...
Elizabeth Adams Whic...
Senior Scientist
Feng Zhao
Principal Research Associate
Glen Carll
Senior System Engineer
Jike Cui
Director of Computational Biol...
Morgan Harris, Pharm...
Associate Director Clinical Sc...
Patrick Trojer
Chief Scientific Officer
Sandra Klein
Clinical Scientist, Associate ...
zehua chen
Associate Director, Computatio...
View all